Patterns and predictors of off-label prescription of psychiatric drugs.
Off-label prescribing of psychiatric drugs is common, despite lacking strong scientific evidence of efficacy and potentially increasing risk for adverse events. The goal of this study was to characterize prevalence of off-label prescriptions of psychiatric drugs and examine patient and clinician pre...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC6053129?pdf=render |
| _version_ | 1819020018029953024 |
|---|---|
| author | Aishwarya Vijay Jessica E Becker Joseph S Ross |
| author_facet | Aishwarya Vijay Jessica E Becker Joseph S Ross |
| author_sort | Aishwarya Vijay |
| collection | DOAJ |
| description | Off-label prescribing of psychiatric drugs is common, despite lacking strong scientific evidence of efficacy and potentially increasing risk for adverse events. The goal of this study was to characterize prevalence of off-label prescriptions of psychiatric drugs and examine patient and clinician predictors of off-label use. This manuscript presents a retrospective, cross-sectional study using data from the 2012 and 2013 National Ambulatory Medical Care Surveys (NAMCS). The study examined all adult outpatient visits to psychiatric practices for chronic care management with a single listed visit diagnosis in which at least one psychiatric drug was prescribed. The main outcome measure was off-label prescribing of at least one psychiatric drug, defined as prescription for a condition for which it has not been approved for use by the FDA. Among our sample representative of 1.85 billion outpatient visits, 18.5 million (1.3%) visits were to psychiatrists for chronic care management in which at least one psychiatric drug was prescribed. Overall, the rate of off-label use was 12.9% (95% CI: 12.2-15.7). The most common off-label uses were for manic-depressive psychosis treated with citalopram and primary insomnia treated with trazodone. Several patient and clinician characteristics were positively associated with off-label prescribing, including seeing a psychiatrist (OR: 1.06, 95% CI, 1.01-1.12; p = 0.03) instead of another type of clinician, the office visit taking place in the Western region of the country (OR: 1.09, 95% CI, 1.01-1.17; p = 0.02), and the patient having 3 or more chronic conditions (OR: 1.12, 95% CI, 1.02-1.14; p = 0.003). In contrast, having Medicare coverage (OR: 0.93, 95% CI, 0.84-0.97; p = 0.04) and receiving payment assistance from a medical charity (OR: 0.91, 95% CI, 0.88-0.96; p = 0.03) instead of private insurance were negatively associated with off-label prescribing. These results suggest that certain classes of psychiatric medications are being commonly prescribed to treat conditions for which they have not been determined by the FDA to be clinically efficacious and/or safe. |
| first_indexed | 2024-12-21T03:44:32Z |
| format | Article |
| id | doaj.art-a2703237934d49df8db6c15340d3b76e |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T03:44:32Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-a2703237934d49df8db6c15340d3b76e2022-12-21T19:17:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01137e019836310.1371/journal.pone.0198363Patterns and predictors of off-label prescription of psychiatric drugs.Aishwarya VijayJessica E BeckerJoseph S RossOff-label prescribing of psychiatric drugs is common, despite lacking strong scientific evidence of efficacy and potentially increasing risk for adverse events. The goal of this study was to characterize prevalence of off-label prescriptions of psychiatric drugs and examine patient and clinician predictors of off-label use. This manuscript presents a retrospective, cross-sectional study using data from the 2012 and 2013 National Ambulatory Medical Care Surveys (NAMCS). The study examined all adult outpatient visits to psychiatric practices for chronic care management with a single listed visit diagnosis in which at least one psychiatric drug was prescribed. The main outcome measure was off-label prescribing of at least one psychiatric drug, defined as prescription for a condition for which it has not been approved for use by the FDA. Among our sample representative of 1.85 billion outpatient visits, 18.5 million (1.3%) visits were to psychiatrists for chronic care management in which at least one psychiatric drug was prescribed. Overall, the rate of off-label use was 12.9% (95% CI: 12.2-15.7). The most common off-label uses were for manic-depressive psychosis treated with citalopram and primary insomnia treated with trazodone. Several patient and clinician characteristics were positively associated with off-label prescribing, including seeing a psychiatrist (OR: 1.06, 95% CI, 1.01-1.12; p = 0.03) instead of another type of clinician, the office visit taking place in the Western region of the country (OR: 1.09, 95% CI, 1.01-1.17; p = 0.02), and the patient having 3 or more chronic conditions (OR: 1.12, 95% CI, 1.02-1.14; p = 0.003). In contrast, having Medicare coverage (OR: 0.93, 95% CI, 0.84-0.97; p = 0.04) and receiving payment assistance from a medical charity (OR: 0.91, 95% CI, 0.88-0.96; p = 0.03) instead of private insurance were negatively associated with off-label prescribing. These results suggest that certain classes of psychiatric medications are being commonly prescribed to treat conditions for which they have not been determined by the FDA to be clinically efficacious and/or safe.http://europepmc.org/articles/PMC6053129?pdf=render |
| spellingShingle | Aishwarya Vijay Jessica E Becker Joseph S Ross Patterns and predictors of off-label prescription of psychiatric drugs. PLoS ONE |
| title | Patterns and predictors of off-label prescription of psychiatric drugs. |
| title_full | Patterns and predictors of off-label prescription of psychiatric drugs. |
| title_fullStr | Patterns and predictors of off-label prescription of psychiatric drugs. |
| title_full_unstemmed | Patterns and predictors of off-label prescription of psychiatric drugs. |
| title_short | Patterns and predictors of off-label prescription of psychiatric drugs. |
| title_sort | patterns and predictors of off label prescription of psychiatric drugs |
| url | http://europepmc.org/articles/PMC6053129?pdf=render |
| work_keys_str_mv | AT aishwaryavijay patternsandpredictorsofofflabelprescriptionofpsychiatricdrugs AT jessicaebecker patternsandpredictorsofofflabelprescriptionofpsychiatricdrugs AT josephsross patternsandpredictorsofofflabelprescriptionofpsychiatricdrugs |